scholarly article | Q13442814 |
P50 | author | Peter Fratzl | Q18412191 |
P2093 | author name string | Rodan GA | |
Yates J | |||
Klaushofer K | |||
Roschger P | |||
Rinnerthaler S | |||
P2860 | cites work | The mineralization density of iliac crest bone from children with osteogenesis imperfecta | Q30635476 |
Bone matters: are density increases necessary to reduce fracture risk? | Q33855012 | ||
Bone mineralization in an osteogenesis imperfecta mouse model studied by small-angle x-ray scattering | Q37350318 | ||
Collagen from the osteogenesis imperfecta mouse model (oim) shows reduced resistance against tensile stress | Q37369430 | ||
Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis | Q37372546 | ||
Mineral density quantitation of the human cortical iliac crest by backscattered electron image analysis: Variations with age, sex, and degree of osteoarthritis | Q39377094 | ||
Bone mineralization as studied by small-angle x-ray scattering | Q41400849 | ||
Bone mineral density reflects bone mass but also the degree of mineralization of bone: therapeutic implications | Q41632573 | ||
Age- and genotype-dependence of bone material properties in the osteogenesis imperfecta murine model (oim). | Q46288750 | ||
Effect of estrogen suppression on the mineralization density of iliac crest biopsies in young women as assessed by backscattered electron imaging | Q46291966 | ||
Mineral crystals in calcified tissues: a comparative study by SAXS. | Q46297259 | ||
Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group | Q48527134 | ||
Static and dynamic bone histomorphometry in children with osteogenesis imperfecta. | Q50660578 | ||
The microscopic structure of bone in normal children and patients with osteogenesis imperfecta: a survey using backscattered electron imaging. | Q52181104 | ||
Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. Early Postmenopausal Intervention Cohort Study Group. | Q53960617 | ||
Effects of sodium fluoride and alendronate on the bone mineral in minipigs: a small-angle X-ray scattering and backscattered electron imaging study. | Q53961475 | ||
Material Properties of Bone from the Femoral Neck and Calcar Femorale of Patients with Osteoporosis or Osteoarthritis | Q57633616 | ||
Multinational, Placebo-Controlled, Randomized Trial of the Effects of Alendronate on Bone Density and Fracture Risk in Postmenopausal Women with Low Bone Mass: Results of the FOSIT Study | Q58868250 | ||
Alendronate Prevents Postmenopausal Bone Loss in Women without Osteoporosis: A Double-Blind, Randomized, Controlled Trial | Q58972083 | ||
Scanning Small Angle X-ray Scattering Analysis of Human Bone Sections | Q63761801 | ||
Validation of quantitative backscattered electron imaging for the measurement of mineral density distribution in human bone biopsies | Q63761811 | ||
Mineralization of cancellous bone after alendronate and sodium fluoride treatment: A quantitative backscattered electron imaging study on minipig ribs | Q63761820 | ||
Abnormal bone mineralization after fluoride treatment in osteoporosis: A small-angle x-ray-scattering study | Q63761854 | ||
Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women | Q73150132 | ||
Determining mineral content variations in bone using backscattered electron imaging | Q73327505 | ||
How does antiresorptive therapy decrease the risk of fracture in women with osteoporosis? | Q73920178 | ||
Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group | Q74817608 | ||
P433 | issue | 2 | |
P921 | main subject | osteoporosis | Q165328 |
P304 | page(s) | 185-191 | |
P577 | publication date | 2001-08-01 | |
P1433 | published in | Bone | Q15755003 |
P1476 | title | Alendronate increases degree and uniformity of mineralization in cancellous bone and decreases the porosity in cortical bone of osteoporotic women | |
P478 | volume | 29 |